Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients

Clinica Chimica Acta

Volumn 354, Issue 1-2, 2005, Pages 123-130

  García Berrocal, Belén ^a   González, Concepción ^a,b   Pérez, Marta ^a   Navajo, José A ^a   Moreta, Isabel ^a   Dávila, Carmen ^a   González Buitrago, José M ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Anti CCP antibodies; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

EID: 14644390848     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.11.025     Document Type: Article

References (29)

1. D.M. Lee, and M.E. Weinblatt Rheumatoid arthritis Lancet 358 2001 903 911
2. G.A. Schellekens, B.A.W. de Jong, F.H.J. van den Hoogen, L.B.A. van de Putte, and W.J. van Venrooij Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J. Clin. Invest. 101 1998 273 281
3. G.A. Schellekens, H. Visser, B.A.W. de Jong, F.H.J. van den Hoogen, J.M.W. Hazes, and F.C. Breedveld The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum. 43 2000 155 163
4. E.J. Kroot, B.A. de Jong, M.A. van Leuwen, H. Swinkels, F.H. van den Hoogen, and M. van't Hof The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum. 43 2000 1831 1835
5. S. Nijenhuis, A.J.W. Zendman, E.R. Vossenaar, G.J.M. Pruijn, and W.J. van Venrooij Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker Clin. Chim. Acta 350 2004 17 34
6. W.J. Van Venrooij, J.M. Hazes, and H. Visser Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis Neth. J. Med. 60 2002 383 388
7. M.M.J. Nielen, D. van Schaardenburg, H.W. Reesink, R.J. van de Stadt, I.E. van der Horst_bruinsma, and M.H. de Koning Specific autoantibodies precede the symptoms of rheumatoid arthritis Arthritis Rheum. 50 2004 380 386
8. F.A. Van Gaalen, S.P. Linn-Rasker, W.J. van Venrooij, B.A. de Jong, F.C. Breedveld, and C.L. Verweij Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis Arthritis Rheum. 50 2004 709 715
9. A.L. Jansen, I. van der Horst-Bruinsma, D. van Schaardenburg, R.J. van de Stadt, M.H. de Koning, and B.A. Dijkmans Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis J. Rheumatol. 29 2002 2074 2076
10. A. Saraux, J.M. Berthelot, V. Devauchelle, B. Bendaoud, G. Chales, and C. Le Henaff Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis J. Rheumatol. 30 2003 2535 2539
11. H. Visser, S.L. Le Cessie, K. Vos, F.C. Breedveld, and J.M. Hazes How to diagnose rheumatoid arthritis early Arthritis Rheum. 46 2002 357 365
12. O. Meyer, C. Labarre, M. Dougados, P. Goupille, A. Cantagrel, and A. Dubois Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five years radiographic damage Ann. Rheum. Dis. 62 2003 120 126
13. E. Lindqvist, K. Eberhardt, K. Bendtzen, D. Heinegard, and T. Saxne Prognostic laboratory markers of joint damage in rheumatoid arthritis Ann. Rheum. Dis. 2004 10.1136/ard.2003.019992 [Published Online First, 30 September 2004]
14. J. Vencovsky, S. Machacek, L. Sedova, J. Kafkova, J. Gatterrova, and V. Pesakova Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann. Rheum. Dis. 62 2003 427 430
15. A. Kastbom, G. Strandberg, A. Lindroos, and T. Skogh Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (The Swedish TIRA project) Ann. Rheum. Dis. 63 2004 1085 1089
16. K. Forslind, M. Ahlmen, K. Eberhardt, I. Hafström, and B. Svensson Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann. Rheum. Dis. 63 2004 1090 1095
17. F. Bobbio-Pallavicini, C. Alpini, R. Caporali, S. Avalle, S. Bugatti, and C. Montecucco Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment Arthritis Res. Ther. 6 2004 R264 R272
18. C. Alessandri, M. Bombardieri, N. Papa, M. Cinquini, L. Magrini, and A. Tincani Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement Ann. Rheum. Dis. 63 2004 1218 1221
19. D. Aletaha, G. Eberl, V.P.K. Nell, K.P. Machold, and J.S. Smolen Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey Ann. Rheum. Dis. 63 2004 1269 1275
20. W. Swedler, J. Wallman, C.J. Froelich, and M. Teodorescu Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity and predictive value for rheumatoid arthritis J. Rheumatol. 24 1997 1037 1044
21. T. Jonsson, K. Steinsson, H. Jonsson, A.J. Geirsson, J. Thorsteinsson, and H. Valdimarsson Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis Rheumatol. Int. 18 1998 119 122
22. A.E. Voskuyl, J.M. Hazes, A.H. Zwinderman, E.M. Paleolog, F.J. van der Meer, and M.R. Daha Diagnostic strategy for the assessment of rheumatoid arthritis Ann. Rheum. Dis. 62 2003 407 413
23. J.A. Hanley, and B.J. Mc Neil Method comparing the areas under receiver operating characteristics curves derived from the same cases Radiology 148 1983 839 843
24. J.C. Wasmuth, D. Oliver y Miñarro, A. Homrighausen, L. Leifield, J.K. Rockstron, and T. Sauerbruch Phospholipid autoantibodies and the antiphospholipid antibody syndrome: diagnostic accuracy of 23 methods studied by variations in ROC curves with the number of clinical manifestations Clin. Chem. 48 2002 1004 1010
25. S. Rantapää-Dahlqvist, B.A.W. de Jong, E. Berglin, G. Hallmans, G. Wadell, and H. Stenlund Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum. 48 2003 2741 2749
26. M. van Boekel, E.R. Vossernaar, F. van den Hoogen, and W.J. van Venrooij Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value Arthritis Res. 4 2 2002 87 93
27. E. Berglin, L. Padyukov, U. Sundin, G. Hallmans, H. Stenlund, and W.J. van Venrooij A Combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis Arthritis Res. Ther. 6 2004 R303 R308
28. F.A. van Gaalen, J. van Aken, T.W.J. Huizinga, G.M. Schreuder, F.C. Breedveld, and E. Zanelli Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Arthritis Rheum. 50 2004 2113 2121
29. S. Bas, T.V. Perneger, E. Kunzle, and T.I. Vischer Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors Ann. Rheum. Dis. 61 2002 505 510